نتایج جستجو برای: hodgkin disease

تعداد نتایج: 1503406  

Journal: :Blood 2012
Lynn I Levin Ellen T Chang Richard F Ambinder Evelyne T Lennette Mark V Rubertone Risa B Mann Michael Borowitz Edward G Weir Susan L Abbondanzo Nancy E Mueller

An altered anti-Epstein-Barr virus (EBV) serologic profile preceding diagnosis is associated with an increased risk of Hodgkin lymphoma. It is unknown whether this atypical pattern predicts Hodgkin lymphoma risk further subdivided by determination of EBV in tumor cells. A nested case-control study of 128 incident Hodgkin lymphoma cases and 368 matched controls from active-duty military personne...

Journal: :international journal of hematology-oncology and stem cell research 0
nasim valizadeh hematology- medical oncology department, emam khomeini hospital, urmia university of medical science, urmia, iran haleh ayatollahi gynecology & obstetric department, motahari hospital, urmia university of medical sciences, urmia, iran siamak naji pathology department, motahari hospital, urmia university of medical sciences, urmia, iran

background : there are only a few reports that exist regarding primary non-hodgkin lymphoma of the genital tract. in this article, one case of primary b-cell type non-hodgkin lymphoma (nhl) of the cervix is presented. case history: a 45 year-old woman presented bloody vaginal  discharge. upon vaginal examination, the cervix was found to be enlarged. cervical biopsy revealed b-cell type non-hodg...

Journal: :Blood 2005
Daniel Re Roman K Thomas Karolin Behringer Volker Diehl

Reclassification of Hodgkin disease as Hodgkin lymphoma (HL) represents a milestone in the lymphoma field, awarding recent insights in the molecular biology of Hodgkin and Reed-Sternberg (H-RS) cells and their environment. This review summarizes antiapoptotic and proproliferative pathways involved in the pathogenesis of this disease with the ultimate goal of translating laboratory knowledge int...

2015
SC Firulescu DL Săndulescu ŞC Dinescu IA Gheonea RM Purcarea SM Săndulescu

UNLABELLED Non-Hodgkin lymphoma is a cancer of the lymphatic tissue located in various parts of the body: lymph nodes, spleen, thymus, adenoids, tonsils, and bone marrow. The disease occurs mainly in adults, with a higher incidence within the age range of 45 to 60 years. We present a clinical case of non-Hodgkin lymphoma diagnosed in a patient with chronic viral hepatitis B and D. The particula...

Journal: :گوارش 0
h ashraf p norouzi s jafari

diffuse hepatic inltration is an unusual form of hodgkin's disease (hd). its manifestation as progressive hepatitis or with hepatic failure is even rarer and can be difcult to diagnose. we aim to describe an unusual case of liver failure due to hd. a middle-aged woman with a 10 month history of daily febrile episodes, constitutional symptoms and strikingly high levels of serum ferritin was admi...

Journal: :Blood 2004
Karl S Peggs Kirsty Thomson Daniel P Hart Johanne Geary Emma C Morris Kwee Yong Anthony H Goldstone David C Linch Stephen Mackinnon

Data on the application of donor lymphocyte infusions (DLIs) following reduced-intensity transplantation (RIT) remain limited. Persistence of host antigen-presenting cells might increase the efficacy or toxicity of cellular immunotherapies. We report the results of dose-escalating DLIs in 46 patients undergoing RIT, who received a total of 109 infusions to treat mixed chimerism or residual or p...

Journal: :Blood 2011
Giuseppe Visani Lara Malerba Pietro Maria Stefani Saveria Capria Piero Galieni Francesco Gaudio Giorgina Specchia Giovanna Meloni Filippo Gherlinzoni Claudio Giardini Sadia Falcioni Francesca Cuberli Marco Gobbi Barbara Sarina Armando Santoro Felicetto Ferrara Marco Rocchi Enrique M Ocio Maria Dolores Caballero Alessandro Isidori

We designed a phase 1-2 study to evaluate the safety and the efficacy of increasing doses of bendamustine (160 mg/m², 180 mg/m², and 200 mg/m² given on days -7 and -6) coupled with fixed doses of etoposide, cytarabine, and melphalan (BeEAM regimen) as the conditioning regimen to autologous stem cell transplantation for resistant/relapsed lymphoma patients. Forty-three patients (median age, 47 y...

2016
Mira Romany Massoud Paolo Fabrizio Caimi Nicole Ferrari Pingfu Fu Richard Creger Robert Fox Joanne Carlson-Barko Merle Kolk Lauren Brister Brenda Wimpfheimer Cooper Stanton Gerson Hillard Michael Lazarus Marcos de Lima Basem Magdy William

INTRODUCTION Allogeneic hematopoietic stem cell transplantation offers the opportunity for extended survival in patients with Hodgkin's and non-Hodgkin lymphomas who relapsed after, or were deemed ineligible for, autologous transplantation. This study reports the cumulative experience of a single center over the past 14 years aiming to define the impact of patient, disease, and transplant-relat...

Journal: :Indian Journal of Dermatopathology and Diagnostic Dermatology 2014

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید